258 IL-9 and IL-13), Th1/Th17 cytokines (IL-2, IFN- and IL-17), proinflammatory cytokines (IL-6 259 and TNF-α), and the anti-inflammatory cytokine (IL-10) production by CBA (Fig 4 and 260 Supplementary Figure S2 ). Levels reached significance versus control vaccinated mice for IL-261 5 (Fig 4A; ES vaccinated mice) and IFN- ( Fig 4D; VLP+T cell epitope vaccinated mice) with 262 non-significant increases in IL-9 and IL-13 ( Fig 4B, 4C) . MLN cells from all vaccinated mouse 263 groups also produced IL-4, IL-6, IL-10, IL-17 and TNF upon their re-stimulation in vitro 264 ( Supplementary Figure S2 A-E). Collectively these data support the in vivo immunogenicity of 265 the novel VLP+ T cell epitope vaccine, evidencing the presence of a mixed Th1/Th2 immune 266 response and are in keeping with the worm expulsion and antibody data. Proximal colon 267 goblet cells were quantified in mice vaccinated with ES/Alum, PBS, VLP (HBc-Ag) and
268 VLPs+T-cell epitopes day 14 post T. muris infection. ( Fig 4E) . Interestingly, VLPs+T-cell 269 epitopes and ES/Alum vaccinated mice exhibited a significantly elevated goblet cell 270 hyperplasia (P<0.05) compared to mice injected with PBS or native VLP (HBc-Ag) ( Fig 4F) .
272

Discussion
273
274 Trichuris trichiura is one of the most common human STH parasites and remains a major 275 health concern for humans worldwide (1). A number of pre-clinical vaccines against trichuriasis 276 have been reported, containing whole Trichuris antigens or fractions (6, 7, 22). However, 277 developing a vaccine for Trichuris based on native antigens has several limitations (10). An 278 alternative strategy embraces the use of informatics to predict and assess MHC-II T cell 279 epitopes using criteria to maximize their in vivo protective potential. The fast-growing 302 The IEDB and NetMHC-II 2.2 tools achieved similarly high levels of sensitivity of predicting 303 binding epitopes with high affinities, while Rankpep and SYFPETHI exhibited low sensitivity.
304 Each tool applies different methods of prediction; the IEDB tool uses a quantitative consensus 305 method that combines the strengths of various methods (25); the NetMHC-II 2.2, another 306 quantitative tool, uses an NN-align algorithm and weight matrix (28); and both SYFPEITHI (47) 307 and Rankpep (48) are qualitative tools that use motif PSSMs. All the tools were 'user-friendly' 308 but SYFPETHI was limited in its coverage of mouse and human MHC-II alleles. The IEDB tool 309 has features that the other three do not, including a browser to input protein sequence formats 310 in a National Centre for Biotechnology Information (NCBI) database, seven different prediction 311 methods and an easy method of downloading the prediction output into an Excel spreadsheet.
312 Several studies have compared the performance of different MHC class II peptide binding 313 prediction tools (49-51), but the comparison presented in this study is different for two main 314 reasons. First, the MHC-II prediction tools were selected in a systematic way using 315 inclusion/exclusion criteria. Second, a unique dataset consisting of a new 'test' dataset which 316 has not been used to build or evaluate IEDB was used. For example, Zhao and Sher (2018) 317 evaluated the MHC-II prediction tools hosted on the IEDB analysis resource server using 318 newly available, untested data of both synthetic and naturally processed epitopes. Among the 319 18 predictors that were benchmarked, NetMHC-II outperformed all other tools, including 320 NetMHCIIpan and the consensus method for both MHC class I and class II predictions (52). 326 Despite differences in the datasets used for comparison, these studies agree with the 327 comparison study conducted in our study, which found that the IEDB (consensus) and 328 NETMHC-II 2.2 (ANN) tools are among the best MHC-II prediction tools. However, 329 NetMHCIIpan could not be included in this study because it did not meet the inclusion criteria.
330 Collectively, we recommend the use of IEDB and NETMHC-II 2.2 prediction tools in any MHC 331 class II epitope prediction study to reduce the experimental cost of identifying epitopes. 332 However, the output of these tools needs to be carefully evaluated in vitro and in vivo before 333 they are used to bring an epitope-based vaccine to trial.
334 Since the advent of immunoinformatics tools for prediction of antigenic epitopes and protein 335 analysis, several VLP-based vaccines have been engineered to carry foreign antigens and 336 have proven to be highly immunogenic (54). To our knowledge, the data presented in this 337 study is the first to identify novel Trichuris MHC-II T-cell epitopes as potential vaccine antigen 393 HBc virus-like particle, in particular, is an excellent delivery system for developing potential 394 vaccine candidates for parasites. 395 A proportion of mice vaccinated with VLP+T-cell epitopes produced detectable levels of MLN-396 derived Th2 cytokines IL-5, IL-9, and IL-13 in response to re-stimulation in vitro with Trichuris 397 ES. The Th1 cytokine IFN was also significantly elevated above levels detected in control 398 mice. These data indicate that vaccine-induced protective immunity is characterized by a 399 mixed Th1/Th2 immune response, as has been previously reported (21, 78) . Similarly, Gu et 400 al (78), reported that the protective immunity to Trichinella spiralis infection induced by 401 vaccination with CD4+ T cell epitopes was associated with both Th1 and Th2 cytokines.
402 Whilst the mechanism by which vaccination protects mice from T. muris infection remains 403 unclear, this study reveals that vaccination of mice with VLPs+T-cell epitopes or ES/Alum 404 promoted a marked goblet cell hyperplasia (79). Goblet cells, and the mucins they produce, 405 have been implicated in Th2-mediated defence in mice resistant to a primary T. muris infection 406 (80, 81). However, it remains to be determined whether the goblet cell hyperplasia seen here 407 in vaccinated mice is simply a Th2 correlate or is functionally important in the protection 408 observed. In summary, the current study describes the development and efficacy of a novel 409 epitope-based vaccine against trichuriasis. VLPs expressing different Trichuris MHC-II T-cell 410 epitopes, predicted from chitin-binding domain containing proteins and chymotrypsin-like 411 serine proteases, were shown to promote protective immunity in vivo. Collectively, given the 412 right combination of immunoinformatics and immunogenicity screening tools, epitope-based 413 vaccines will undoubtedly limit the cost and effort associated with bringing a Trichuris vaccine 414 to trial.
416
Methods 417 Search strategy. A protocol was designed to identify the bioinformatics tools that can predict 418 MHC-II T-cell epitopes in accordance with the well-defined Preferred Reporting Items for 419 Systematic Reviews and Meta-Analyses (PRISMA) (82). The search was limited to the English 587 cells was determined as the total number of PAS-positive cells in 60 randomly selected crypts 588 in three fields of view from each section.
589 Statistics Statistical analyses were performed using Graph Pad Prism, version 7.00 software.
590 In all tests, P≤0.05 were considered statistically significant and were determined using the 591 Kruskal-Wallis non-parametric ANOVA for comparing multiple groups.
592
